Comparing the clinical outcomes of initial surgery and primary definitive radiotherapy with a dosage of 6600 cGy or higher in cT1−2N0M0 oral cavity squamous cell carcinoma: A nationwide cohort study

Chien‐Yu Lin,Wen‐Cheng Chen,Yu‐Wen Wen,Kang‐Hsing Fan,Jin‐Ching Lin,Shu‐Hang Ng,Yao‐Te Tsai,Shu‐Ru Lee,Chung‐Jan Kang,Li‐Yu Lee,Chih‐Yen Chien,Chun‐Hung Hua,Cheng Ping Wang,Tsung‐Ming Chen,Shyuang‐Der Terng,Chi‐Ying Tsai,Hung‐Ming Wang,Chia‐Hsun Hsieh,Chih‐Hua Yeh,Chih‐Hung Lin,Chung‐Kan Tsao,Nai‐Ming Cheng,Tuan‐Jen Fang,Shiang‐Fu Huang,Li‐Ang Lee,Ku‐Hao Fang,Yu‐Chien Wang,Wan‐Ni Lin,Li‐Jen Hsin,Tzu‐Chen Yen,Chun‐Ta Liao
DOI: https://doi.org/10.1002/cam4.7127
IF: 4.711
2024-05-22
Cancer Medicine
Abstract:Patients with cT1−2N0M0 oral cavity cancer who underwent initial surgery demonstrated significantly improved disease‐specific and overall survival rates compared to those who received primary definitive radiotherapy (≥6600 cGy), even after propensity score matching. Subgroup analyses further revealed that survival outcomes remained significantly better for the positive margin subgroup compared to the radiotherapy group, irrespective of whether they received concurrent chemotherapy. Background To compare the clinical outcomes of two treatment modalities, initial surgery and primary definitive radiotherapy (RT), in Taiwanese patients diagnosed with cT1−2N0M0 oral cavity squamous cell carcinoma (OCSCC). Methods Between 2011 and 2019, we analyzed data for 13,542 cT1−2N0M0 patients who underwent initial surgery (n = 13,542) or definitive RT with a dosage of at least 6600 cGy (n = 145) for the treatment of OCSCC. To account for baseline differences, we employed propensity score (PS) matching, resulting in two well‐balanced study groups (initial surgery, n = 580; definitive RT, n = 145). Results Before PS matching, the 5‐year disease‐specific survival (DSS) rates were 88% for the surgery group and 58% for the RT group. After PS matching, the 5‐year DSS rates of the two groups were 86% and 58%, respectively. Similarly, the 5‐year overall survival (OS) rates before PS matching were 80% for the surgery group and 36% for the RT group, whereas after PS matching, they were 73% and 36%, respectively. All these differences were statistically significant (p
oncology
What problem does this paper attempt to address?